3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Hematologic Neoplasms
2
Xerostomia Due to Radiotherapy (Disorder)
1
Ulcer
1
Stomatitis
1
Squamous Cell Carcinoma of Head and Neck
1
Seizures
1
Renal Insufficiency
1
Progressive Metastatic Castrate Resistant Prostate Cancer
1
Kidney Failure, Chronic
1
Inflammatory Bowel Diseases
1
Head and Neck Neoplasms
1
Glioma
1
Carcinoma, Renal Cell
1
COVID-19
1
Breast Neoplasms
1
Advanced/Metastatic Solid Tumors
1
2019 Novel Coronavirus
1
Interventions
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Progressive Metastatic Castrate Resistant Prostate Cancer
×
Standard of Care
×
Clear all
NCT07206056
2026-06-03
TulmiSTAR-01
Novartis
Phase 1/2
Recruiting
188 enrolled